X
FDA approves Bayer/Janssen’s Xarelto in new blood clot prevention use
https://pharmaphorum.com/news/fda-approves-bayer-janssens-xarelto-in-new-blood-clot-prevention-use/
Bristol-Myers Squib
Keytruda wins another first with approval based on biomarkers
For the first time, FDA approves drug on the basis of biomarkers, rather than location.